Smad3 mediates ANG II-induced hypertensive kidney disease in mice.

scientific article published on 11 January 2012

Smad3 mediates ANG II-induced hypertensive kidney disease in mice. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPRENAL.00595.2011
P698PubMed publication ID22237801

P2093author name stringZhen Liu
Hui Y Lan
Xiao R Huang
P2860cites workSmad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradationQ24290777
Mechanisms of TGF-beta signaling from cell membrane to the nucleusQ27860785
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesQ28188162
Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3Q28569602
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-betaQ28594801
Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.Q30499402
Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signalingQ33711306
Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-betaQ33902166
Hypertensive nephropathy: prevention and treatment recommendationsQ34131899
Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.Q34455322
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in miceQ34514594
The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potentialQ34527184
Essential role of Smad3 in angiotensin II-induced vascular fibrosisQ34575283
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseasesQ36310340
Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathwayQ36598311
Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstructionQ36991087
Smad7 as a therapeutic agent for chronic kidney diseases.Q37175439
Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implicationQ37244477
NF-kappaB in renal inflammationQ37774798
Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesisQ37896399
Diverse roles of TGF-β/Smads in renal fibrosis and inflammationQ37934555
Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.Q40443101
Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cellsQ40927675
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosisQ41695601
Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuriaQ43615549
Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S ratsQ44107276
Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.Q44486199
Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.Q45000528
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.Q45270277
Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney.Q45308027
Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO modelQ45862411
Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.Q45867788
Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanismQ46481430
Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic ratsQ46691716
Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney diseaseQ46837580
Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.Q52590979
P433issue8
P921main subjectkidney diseaseQ1054718
P304page(s)F986-97
P577publication date2012-01-11
P1433published inAmerican Journal of Physiology - Renal PhysiologyQ2610177
P1476titleSmad3 mediates ANG II-induced hypertensive kidney disease in mice.
P478volume302

Reverse relations

cites work (P2860)
Q37419118Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
Q35838004Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats
Q51169038Association study of common variations of FBN1 gene and essential hypertension in Han Chinese population
Q60222307Captopril mitigates splenomegaly and myelofibrosis in the Gata1 murine model of myelofibrosis
Q36142616Cofilin1 is involved in hypertension-induced renal damage via the regulation of NF-κB in renal tubular epithelial cells
Q37093818Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways
Q34875675Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension
Q38959449Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury
Q34542559Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
Q91650519Diverse Role of TGF-β in Kidney Disease
Q99708624Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy
Q36575572Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease
Q35082779Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney.
Q92308460Ginsenoside Rg3 Attenuates Angiotensin II-Mediated Renal Injury in Rats and Mice by Upregulating Angiotensin-Converting Enzyme 2 in the Renal Tissue
Q92618428Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway
Q60938842JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-B Signaling-Mediated Microinflammation
Q52668596Kidney disease models: tools to identify mechanisms and potential therapeutic targets.
Q36756684Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation
Q53499188Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.
Q38861678Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts.
Q38062404Molecular targets for treatment of kidney fibrosis
Q92310282PROTACs: great opportunities for academia and industry
Q61814799Regulation of TGF-β1 on PI3KC3 and its role in hypertension-induced vascular injuries
Q38020840Regulation of the transforming growth factor β pathway by reversible ubiquitylation
Q64275933Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats
Q36796579Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase
Q54282708Renoprotective effects of sildenafil in DOCA-salt hypertensive rats.
Q41857602Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation
Q38598542Role of Smad signaling in kidney disease
Q28278757Role of the TGF-β/BMP-7/Smad pathways in renal diseases
Q51039701SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells
Q38888431ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
Q47822539Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α.
Q35058888Smad3 deficiency ameliorates hepatic fibrogenesis through the expression of senescence marker protein-30, an antioxidant-related protein
Q50588263Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance.
Q35828473Smad7 protects against chronic aristolochic acid nephropathy in mice
Q55242511Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Q48611625TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis.
Q26851198TGF-β/Smad signaling in renal fibrosis
Q28067425TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
Q47313741The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3.
Q99584180Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in Mice
Q36545653Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.
Q39413020miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling

Search more.